Margin resik: Radiopharm Theranostics Limited (RADX)

Tandha merek Radiopharm Theranostics (RADX)

Aggregate net margins on the GURU.Markets chart correlate with the expansion of licensing agreements with universities, where the parameter value equals -1994.10. Radiopharm Theranostics (RADX) bases its efficiency growth on patent protection for isotopes, which creates barriers for competitors. The stability of these indicators is supported by the implementation of robotic molecule labeling, which minimizes production defects and eliminates employee radiation exposure in laboratories.

Margin bathi resik radiopharmtheranostics.com (RADX): kanggo periode 06.12.2024 - 20.11.2026

RADX (Radiopharm Theranostics Ltd): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Radiopharm Theranostics
Barang unggulan Radiopharm Theranostics Limited

The metric is calculated as the ratio of net income to total revenue over a specific period. This metric determines the efficiency of converting revenue into the final financial result. For Radiopharm Theranostics (RADX), it reflects the ability to monetize developments in targeted radioisotopes while accounting for high R&D costs. An analysis of historical net margins allows for an assessment of the business's resilience to operating expenses. Positive momentum along this curve indicates an increase in the capitalization of the company's scientific potential.

Pesaing utama

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|UroGen Pharma - Rentabilitas dodolan resik|Bicara Therapeutics - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Personalis Inc PSNL|Erasca Oncology - Margin dodolan resik|Tingkat bathi resik DCTH (Delcath Corp)|YMAB: Margin dodolan resik|AURA - Margin dodolan perusahaan|CADL (Candel Therapeutics Inc.) - Margin dodolan resik|Rentabilitas dodolan resik ARAY (Accuray)|Rentabilitas dodolan miturut bathi resik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Margin resik|Margin resik Citius Oncology, Inc. CTOR|HURA - Rentabilitas dodolan miturut bathi resik|protaratx.com - Margin dodolan resik|FATE - Margin dodolan resik|WHWK: Margin dodolan resik|TScan Therapeutics (TCRX) - Margin dodolan resik|Margin resik Champions Oncology|Margin resik XBIT|Margin dodolan resik CVM|Rentabilitas dodolan miturut bathi resik OS Therapies Inc. OSTX|Margin dodolan resik ARTV (Artiva Biotherapeutics)|Margin dodolan resik Adlai Nortye Ltd. ANL|Veru Inc - Margin dodolan resik|Margin dodolan perusahaan Tempest Therapeutics TPST|XLO: Margin dodolan resik|Enochian BioSciences (RENB) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MURA|Kairos Pharma Ltd - Margin bathi resik|Margin dodolan resik OKUR|CytoMed Therapeutics Limited (GDTC) - Tingkat bathi miturut bathi resik|Margin dodolan resik CRIS (Curis, Inc.)|APLM: Rentabilitas dodolan resik|Tharimmune Corporation - Margin dodolan resik|ADVB: Margin resik|GNPX: Margin dodolan resik|CLDI (Calidi Biotherapeutics Inc.) - Margin resik|Margin resik Sunshine Biopharma, Inc.|Margin dodolan resik xeneticbio.com|Margin resik Salarius (SLRX)|Rentabilitas dodolan miturut bathi resik Purple Biotech PPBT|Margin resik American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Margin resik|Checkpoint Therapeutics Inc. - Margin dodolan resik|Tingkat bathi resik ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Rentabilitas dodolan miturut bathi resik|Ikena Oncology, Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NTBL|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)